Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
ClinicalTrials.gov study NCT06465160. IPD Sharing: NO. Countries: 1. Publications: 0.
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
ClinicalTrials.gov study NCT04284228. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00148980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
ClinicalTrials.gov study NCT05986240. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML)
ClinicalTrials.gov study NCT03801005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
ClinicalTrials.gov study NCT04713956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02141477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
ClinicalTrials.gov study NCT06630221. IPD Sharing: YES. Countries: 1. Publications: 0.
An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01026376. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
ClinicalTrials.gov study NCT05457010. IPD Sharing: NO. Countries: 1. Publications: 0.
Temsirolimus in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01111448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00840931. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Machine Vision Based MDS-UPDRS III Machine Rating
ClinicalTrials.gov study NCT05906719. IPD Sharing: NO. Countries: 1. Publications: 0.
Effectiveness of Protected Environment Rooms for AML and MDS
ClinicalTrials.gov study NCT00443300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
ClinicalTrials.gov study NCT04482894. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
ClinicalTrials.gov study NCT03502668. IPD Sharing: NO. Countries: 6. Publications: 0.
A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
ClinicalTrials.gov study NCT03884829. IPD Sharing: NO. Countries: 1. Publications: 0.
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
ClinicalTrials.gov study NCT01286038. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
ClinicalTrials.gov study NCT03045510. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
ClinicalTrials.gov study NCT02969980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.